Amussen Hunsaker Associates LLC Pds Biotechnology Corp Put Options Transaction History
Amussen Hunsaker Associates LLC
- $715 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.06MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$676,8840.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$577,0070.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$325,5500.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$186,6210.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $39.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...